Walter Ageno Selected Research

Fibrinolytic Agents (Antithrombotic Agents)

7/2020	Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research.
1/2001	Arterial indications for the low molecular weight heparins.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Walter Ageno Research Topics

Disease

139	Venous Thromboembolism 04/2024 - 01/2000
137	Hemorrhage 04/2024 - 01/2000
62	Thrombosis (Thrombus) 03/2024 - 12/2005
48	Venous Thrombosis (Deep-Vein Thrombosis) 02/2024 - 01/2003
46	Atrial Fibrillation 03/2024 - 02/2007
46	Neoplasms (Cancer) 01/2024 - 06/2005
42	Pulmonary Embolism 04/2024 - 07/2003
35	Stroke (Strokes) 03/2024 - 01/2001
18	Ischemic Stroke 10/2022 - 12/2002
17	Thromboembolism 10/2022 - 01/2005
16	COVID-19 10/2023 - 01/2020
11	Thrombocytopenia (Thrombopenia) 12/2023 - 03/2004
11	Embolism (Embolus) 10/2022 - 10/2004
7	Acute Coronary Syndrome 01/2024 - 03/2005
5	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 09/2008
5	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023 - 01/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 06/2022 - 04/2007
5	Renal Insufficiency (Renal Failure) 06/2021 - 01/2008
4	Fibrosis (Cirrhosis) 12/2023 - 02/2014
4	Liver Diseases (Liver Disease) 12/2023 - 05/2007
4	Hypertension (High Blood Pressure) 01/2022 - 07/2012
4	Thrombophilia 08/2014 - 01/2005
3	Portal Hypertension 03/2024 - 12/2021
3	Hemophilia A (Haemophilia) 01/2024 - 05/2007
3	Varicose Veins (Varicose Vein) 12/2023 - 12/2021
3	Wounds and Injuries (Trauma) 05/2023 - 05/2007
3	Disease Progression 01/2023 - 01/2021
3	Inflammation (Inflammations) 01/2022 - 08/2011
3	Heart Failure 06/2021 - 01/2005
3	Atherosclerosis 06/2021 - 10/2010
3	Embolic Stroke 06/2021 - 08/2015
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2021 - 08/2018
3	Lung Neoplasms (Lung Cancer) 10/2020 - 03/2008
3	Hematoma 01/2020 - 08/2008
3	Retinal Vein Occlusion 09/2010 - 09/2007
2	Peripheral Arterial Disease 03/2024 - 01/2022
2	Diabetes Mellitus 01/2023 - 08/2019
2	Overweight 01/2023 - 12/2021
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 11/2022 - 06/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 12/2017
2	Critical Illness (Critically Ill) 08/2022 - 02/2018
2	Uterine Hemorrhage (Uterine Bleeding) 08/2022 - 01/2021
2	Vascular Diseases (Vascular Disease) 01/2022 - 02/2014
2	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2017
2	Infections 01/2022 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 06/2021 - 01/2003
2	Cerebral Hemorrhage 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

169	AnticoagulantsIBA 03/2024 - 08/2002
58	Vitamin K FDA Link 12/2023 - 07/2004
34	RivaroxabanIBA 01/2023 - 06/2008
29	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 02/2024 - 01/2001
28	Warfarin (Coumadin)FDA LinkGeneric 02/2024 - 08/2002
28	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2000
17	fibrin fragment D (D-dimer)IBA 04/2024 - 12/2002
16	Enoxaparin (Lovenox)FDA LinkGeneric 10/2023 - 01/2005
10	apixabanIBA 04/2024 - 01/2013
10	edoxabanIBA 05/2022 - 05/2016
10	Dabigatran FDA Link 01/2022 - 01/2013
10	Factor Xa InhibitorsIBA 01/2021 - 01/2005
7	Fondaparinux (Arixtra)FDA Link 06/2023 - 01/2005
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2015 - 07/2008
6	Dalteparin (Dalteparin Sodium)FDA Link 01/2024 - 01/2005
6	CreatinineIBA 10/2022 - 12/2015
6	Biomarkers (Surrogate Marker)IBA 10/2022 - 07/2004
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2001
5	AntithrombinsIBA 05/2015 - 01/2005
4	Blood Coagulation Factors (Coagulation Factor)IBA 01/2024 - 07/2009
4	pro-brain natriuretic peptide (1-76)IBA 06/2022 - 04/2009
4	betrixabanIBA 02/2020 - 05/2018
4	Blood Group Antigens (Blood Groups)IBA 08/2014 - 07/2012
4	Prothrombin (Factor II)IBA 07/2013 - 01/2005
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 03/2024 - 08/2019
3	COVID-19 VaccinesIBA 01/2023 - 08/2021
3	C-Reactive ProteinIBA 01/2021 - 10/2011
3	Thrombin FDA Link 11/2018 - 03/2016
3	ABO Blood-Group SystemIBA 08/2014 - 02/2013
2	Troponin T (Troponin T1)IBA 01/2024 - 06/2022
2	ORALIT (ORS)IBA 11/2023 - 10/2008
2	Fluorescein (Funduscein)FDA LinkGeneric 01/2023 - 09/2010
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2023 - 12/2022
2	Factor XIa (Coagulation Factor XIa)IBA 01/2023 - 12/2021
2	Factor VIIa (Activated Factor VII)IBA 12/2022 - 05/2007
2	Thromboplastin (Tissue Factor)IBA 12/2022 - 01/2022
2	TroponinIBA 06/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2008
2	Fibrinogen (Factor I)FDA Link 07/2021 - 12/2020
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2021 - 10/2008

Therapy/Procedure

90	Therapeutics 03/2024 - 08/2002
11	Secondary Prevention 01/2022 - 07/2008
7	Contraindications 01/2023 - 04/2012
5	Length of Stay 04/2024 - 08/2017
5	Knee Replacement Arthroplasty (Total Knee Replacement) 12/2021 - 06/2008
5	Thrombolytic Therapy 01/2020 - 04/2015
4	Orthopedic Procedures 01/2024 - 06/2009
4	Duration of Therapy 11/2023 - 07/2003
4	Drug Therapy (Chemotherapy) 09/2020 - 12/2014
4	Catheters 01/2016 - 06/2005
3	Drug Tapering 01/2022 - 09/2016
3	Vena Cava Filters (Inferior Vena Cava Filter) 01/2019 - 02/2008
2	Polypharmacy 06/2021 - 01/2018